Laurion Capital Management LP Zai Lab LTD Transaction History

Laurion Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$81.94 - $135.34 $721,072 - $1.19 Million	-8,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $645,040 - $787,424	8,800 New	8,800 $732,000
Q2 2020 Aug 14, 2020	SELL	$48.82 - $82.53 $244,100 - $412,650	-5,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $195,500 - $314,500	5,000 New	5,000 $257,000
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $314,413 - $519,886	-21,031 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$17.8 - $25.35 $374,351 - $533,135	21,031 New	21,031 $410,000
Q1 2018 May 14, 2018	SELL	$20.05 - $26.96 $834,340 - $1.12 Million	-41,613 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$21.23 - $34.09 $921,106 - $1.48 Million	-43,387 Reduced 51.04%	41,613 $883,000
Q3 2017 Nov 13, 2017	BUY	$27.0 - $31.11 $2.3 Million - $2.64 Million	85,000	85,000 $2.3 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.66B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.